Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine vs Steroids in DRESS
NCT04988256Phase 1Enrolling by invitation
- Sponsor
- University of Southern California
- Start
- Sep 2021
- Primary completion
- Apr 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of cyclosporine in drug reaction with eosinophilia and systemic symptoms (DRESS) (2 arms), sponsored by University of Southern California. Primary endpoints: Percentage of participants with complete or near complete resolution of organ involvement at 30 days and Percentage of participants with complete or near complete resolution of erythema at 30 days. Started Sep 2021; status: enrolling by invitation.
02
Drugs
cyclosporine
03
Conditions
drug reaction with eosinophilia and systemic symptoms (DRESS)
Beyond the preview
Go deeper on NCT04988256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04988256.